Gambling at the age of 17: results of the 2022 survey on health and behaviour during the call to prepare for defence (ESCAPAD)
In a glimpse, OFDT, 2 p.
October 2023
For the third time after 2011 and 2017, the OFDT has administered a module of questions in the ESCAPAD survey on gambling practices among 17-year-old adolescents.
Gambling on the decline, except for casino games
In 2022, more than a quarter of teenagers had gambled during the year, and 4% had done so on a weekly basis. These practices are down compared with 2017. Lottery games are becoming less popular among young people. Despite the football World Cup, sports betting have returned to their 2011 levels in 2022. Finally, casino gambling is up slightly.
Internet use has continued to increase since 2011
There have been changes in the ways in which 17-year-olds gamble; use of the Internet has continued to increase since 2011, despite the regulatory ban. This trend appears to be particularly marked for sports and horse betting. Around one in ten 17-year-old gamblers show signs of problem gambling that may require clinical assessment.
Download In a glimpse, Gambling at the age of 17 (297 Ko, 2p.)
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
